NFKB1 and leiomyoma: Based on our findings and those of others indicating that fibroid tumors are characterized by increased inflammation [12] and activation of NF-kB, we hypothesized that Bay 11-7082 (Bay), an inhibitor of inflammation, could be beneficial for the treatment of fibroids by reducing the expression of proinflammatory genes and inhibiting their growth.